Marco Pravetoni, PhD, recently traveled to DC to represent the potential we have to make a difference in one of the most compelling human crises our country is facing — opioid use disorder and related overdoses. 

Dr. Pravetoni presented his research on vaccines and mAbs to treat/prevent overdose at a Congress briefing attended by the director of the National Institute on Drug Abuse (NIDA) and the director of the Helping End Addiction Long-term (HEAL) Initiative, among others. He was also selected to speak at a NIH HEAL meeting to showcase NIDA’s efforts in immunotherapeutics for opioid use disorder/overdose and he had an opportunity to meet with legislators (including Washington Senator Maria Cantwell) to discuss bills related to health as a member of the Board of Directors for the College on Problems of Drug Dependence (CPDD).

Dr. Pravetoni is one of our many faculty and staff members who are contributing to state and federal policy dialogues and decisions, and we want to thank everyone who is sharing their expertise to advance effective behavioral health care with our local, state, and federal lawmakers.